Tata Motors Q2 FY2025: Net Profit Down by 11%, Revenue Falls by 3.5%
Procter & Gamble Hygiene and Health Care Ltd Q2 Results FY2024, Net profit at Rs.210.69 Crores
Last Updated: 30th October 2023 - 06:16 pm
On 30th October 2023, Procter & Gamble Hygiene and Health Care Ltd announced its quarterly results.
Key Highlights:
- Revenue from Operations was at Rs.1138.35 Crores for Q2FY24 driven by a superior retail execution and integrated growth strategy.
- Profit before tax was reported at Rs. 284.47 Crores
- Net Profit was reported at Rs.210.6 Crores led by acceleration of volume growth coupled with product price-mix and productivity
Business Highlights:
- Strong product offerings, excellent customer service, and a steady flow of innovative products—such as Whisper Hygiene Comfort, Whisper Choice Nights, Vicks ZzzQuil—the world's best sleep supplement—Vicks Roll-On Inhaler, and Vicks Xtra Strong—all contributed to the company's business growth.
- Through its "Whisper Menstrual Health & Hygiene Program," Whisper keeps spreading awareness of the importance of menstrual hygiene education.
Commenting on the results, LV Vaidyanathan, Managing Director, Procter & Gamble Hygiene and Health Care Ltd.said: “We delivered a strong top and bottom-line growth in the quarter, by executing our integrated strategy of a focused product portfolio of daily use categories where performance drives brand choice, superiority — across product performance, packaging, brand communication, retail execution and consumer and customer value —productivity, constructive disruption, and an agile and accountable organization. Our team’s execution of these strategies has enabled us to build momentum in the first quarter, and we are confident that these strategies will help us deliver balanced growth and value creation.”
Trending on 5paisa
05
5paisa Research Team
06
5paisa Research Team
Discover more of what matters to you.
Corporate Actions Related Articles
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.